3D airway tissue model to evaluate agents against SARS-CoV-2

With the rapid spread of SARS-CoV-2, the virus responsible for COVID-19, it is imperative to rapidly deploy therapeutic agents to stop the viral propagation. This application note from zPREDICTA displays the features of its r-Lung-COVID model, a 3D airway tissue model, to identify agents with antiviral activity.